A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)

PHASE4CompletedINTERVENTIONAL
Enrollment

297

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

December 31, 2012

Conditions
Infection, Human Immunodeficiency Virus
Interventions
DRUG

Reyataz + Norvir + Truvada

atazanavir 300mg + ritonavir 100mg + tenofovir 300mg/emtricitabine 200mg

DRUG

Reyataz + Epzicom

atazanavir 400mg + abacavir 600mg/lamivudine 300mg

Trial Locations (46)

10595

GSK Investigational Site, Valhalla

20007

GSK Investigational Site, Washington D.C.

20009

GSK Investigational Site, Washington D.C.

20037

GSK Investigational Site, Washington D.C.

24501

GSK Investigational Site, Lynchburg

27599

GSK Investigational Site, Chapel Hill

28209

GSK Investigational Site, Charlotte

30309

GSK Investigational Site, Atlanta

30339

GSK Investigational Site, Atlanta

31401

GSK Investigational Site, Savannah

32117

GSK Investigational Site, Daytona Beach

32803

GSK Investigational Site, Orlando

33133

GSK Investigational Site, Miami

33137

GSK Investigational Site, Miami

33139

GSK Investigational Site, Miami Beach

33305

GSK Investigational Site, Wilton Manors

33308

GSK Investigational Site, Fort Lauderdale

33401

GSK Investigational Site, West Palm Beach

34982

GSK Investigational Site, Ft. Pierce

36201

GSK Investigational Site, Hobson City

38103

GSK Investigational Site, Memphis

48072

GSK Investigational Site, Berkeley

48824

GSK Investigational Site, East Lansing

55415

GSK Investigational Site, Minneapolis

60613

GSK Investigational Site, Chicago

64106

GSK Investigational Site, Kansas City

75246

GSK Investigational Site, Dallas

77098

GSK Investigational Site, Houston

80220

GSK Investigational Site, Denver

83704

GSK Investigational Site, Boise

85012

GSK Investigational Site, Phoenix

85015

GSK Investigational Site, Phoenix

90069

GSK Investigational Site, Los Angeles

90211

GSK Investigational Site, Beverly Hills

90813

GSK Investigational Site, Long Beach

92103

GSK Investigational Site, San Diego

92663

GSK Investigational Site, Newport Beach

92708

GSK Investigational Site, Fountain Valley

93301

GSK Investigational Site, Bakersfield

94109

GSK Investigational Site, San Francisco

94602

GSK Investigational Site, Oakland

99204

GSK Investigational Site, Spokane

08844

GSK Investigational Site, Hillsborough

07102

GSK Investigational Site, Newark

00717

GSK Investigational Site, Ponce

00909

GSK Investigational Site, San Juan

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY